Why is famciclovir use discouraged during pregnancy?

Why is famciclovir avoided in pregnancy?

Famciclovir is not recommended during pregnancy because animal studies showed developmental harm at doses similar to those used in people, and there is no reliable human safety data to offset that risk. The drug is converted to penciclovir, which crosses the placenta and can interfere with rapidly dividing fetal cells.

What do pregnancy registries show?

A small registry maintained by the manufacturer collected outcomes for 44 women exposed to famciclovir. Two major birth defects were reported, but the numbers are too low to draw firm conclusions. No pattern of defects has emerged yet, but the data remain too limited for routine use.

Can the drug still be used if no alternatives exist?

In rare cases, such as severe herpes zoster in an immunocompromised patient, clinicians may weigh the risk of untreated infection against possible fetal effects. Current guidelines still list famciclovir as pregnancy category B, meaning animal risk exists but controlled human studies are absent.

How does famciclovir compare with acyclovir and valacyclovir?

Acyclovir has the largest human pregnancy database and is generally preferred when antiviral treatment is required. Valacyclovir is also widely used because it converts to acyclovir. Famciclovir lacks comparable exposure data, which is the main reason it is not first-line.

When does the patent on famciclovir expire and what does that mean for generics?

The key U.S. patents expired in 2010, and generic versions have been available since then. Lower prices have increased overall use, but pregnancy labeling has not changed.

[1] DrugPatentWatch.com. Famciclovir patent and exclusivity data. https://www.drugpatentwatch.com/drug/famciclovir